ANCA 相关性血管炎合并症:血栓栓塞与心血管事件
本文综述 ANCA 相关性血管炎(AAV)的血栓栓塞与心血管事件;报告血栓栓塞风险明显升高,与疾病活动和凝血因子异常相关,缓解期也可能存在高凝状态;心血管死亡为主要死因之一,可改变心血管危险因素控制不足。
要点
- AAV 患者血栓栓塞风险明显升高,与疾病活动和凝血因子异常相关。
- 缓解期仍可能存在高凝状态,需研究个体化抗凝策略。
- 心血管死亡为主要死因之一,可改变危险因素控制不足。
核心结论
- AAV 患者血栓栓塞风险明显升高,心血管死亡为主要死因之一,加速性动脉粥样硬化常见。
- 当前可改变心血管危险因素控制不足,建议定期全面评估并按个体心血管风险预测采取治疗。
研究设计与样本
- 综述,聚焦 ANCA 相关性血管炎的血栓栓塞与心血管事件合并症。
主要发现
- 报告血栓栓塞事件风险明显升高,与疾病活动和凝血因子异常相关。
- 越来越多证据提示缓解期患者仍存在高凝状态。
- 高血压、糖尿病和高胆固醇血症高发,可为免疫抑制后果或与基础疾病相关。
临床怎么用
- 按现行推荐进行个体心血管风险预测并治疗可改变危险因素。
- 定期全面复查心血管危险因素,关注缓解期高凝状态。
- 有待研究评估个体化抗凝对减轻血栓栓塞负担的作用。
局限性
- 为叙述性综述,未报告检索策略、样本量或定量合并结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prognosis of patients with ANCA-associated vasculitis has improved over the past decades, but overall survival rates are still unsatisfactory. Recent research has focused on complications of immunosuppressive measures and comorbidities of ANCA-associated vasculitis. This review focuses on thromboembolic and cardiovascular events. A considerably increased risk of thromboembolic events has been reported, which is associated with active disease and impaired coagulation factors. There is mounting evidence that a hypercoagulable state is present even in patients in remission, and studies investigating the impact of tailored anticoagulation are needed to reduce the burden of thromboembolism. Cardiovascular mortality is one of the leading causes of death and accelerated atherosclerosis is frequently observed in patients with ANCA-associated vasculitis. A high frequency of patients develops hypertension, diabetes mellitus and hypercholesterolaemia, either as a consequence of immunosuppression or associated with the underlying disease. The current control of modifiable cardiovascular risk factors is insufficient and thorough reviews should be performed periodically. Treatment of these risk factors should be adopted according to current recommendations related to individual cardiovascular risk prediction.
引用
- Kronbichler A, Leierer J, Gauckler P, et al. Comorbidities in ANCA-associated vasculitis. Rheumatology (Oxford). 2020. PMID: 32348518. doi:10.1093/rheumatology/kez617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。